(Q38095828)

28 August 2017

title

Bone health and human immunodeficiency virus infection (English)

1 reference

28 August 2017

Jason J Schafer

1

1 reference

28 August 2017

Kristine Manlangit

series ordinal

2

1 reference

28 August 2017

Kathleen E Squires

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

665-682

1 reference

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

28 August 2017

cites work

1 reference

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system

21 January 2018

1 reference

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

21 January 2018

1 reference

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans

21 January 2018

1 reference

Premature age-related comorbidities among HIV-infected persons compared with the general population.

21 January 2018

1 reference

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors

21 January 2018

1 reference

Osteoimmunology and the effects of the immune system on bone

21 January 2018

1 reference

HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation

21 January 2018

1 reference

HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk

21 January 2018

1 reference

A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner

21 January 2018

1 reference

B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo

21 January 2018

1 reference

B cells in HIV infection and disease

21 January 2018

1 reference

Continuous antiretroviral therapy decreases bone mineral density

21 January 2018

1 reference

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

21 January 2018

1 reference

Changes in bone mineral density with age in men and women: a longitudinal study

21 January 2018

1 reference

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

21 January 2018

1 reference

Longitudinal analysis of bone density in human immunodeficiency virus-infected women

21 January 2018

1 reference

Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens

21 January 2018

1 reference

Select HIV protease inhibitors alter bone and fat metabolism ex vivo

21 January 2018

1 reference

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling

21 January 2018

1 reference

HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts.

21 January 2018

1 reference

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.

21 January 2018

1 reference

Efavirenz-induced osteomalacia

21 January 2018

1 reference

Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.

21 January 2018

1 reference

Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.

21 January 2018

1 reference

Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States

21 January 2018

1 reference

21 January 2018

1 reference

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

21 January 2018

1 reference

The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy

21 January 2018

1 reference

Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study

21 January 2018

1 reference

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

21 January 2018

1 reference

Bone disease in HIV infection: a practical review and recommendations for HIV care providers

21 January 2018

1 reference

Vitamin D deficiency is less common among HIV-infected African-American men than in a matched cohort.

21 January 2018

1 reference

Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women

21 January 2018

1 reference

25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

21 January 2018

1 reference

25-hydroxyvitamin D levels and the risk of mortality in the general population

21 January 2018

1 reference

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial

21 January 2018

1 reference

Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents

21 January 2018

1 reference

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

21 January 2018

1 reference

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study

21 January 2018

1 reference

Use of the FRAX equation as first-line screening of bone metabolism alteration in the HIV-infected population.

21 January 2018

1 reference

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

21 January 2018

1 reference

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection

21 January 2018

1 reference

Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis.

21 January 2018

1 reference

A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis

21 January 2018

1 reference

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial

21 January 2018

1 reference

Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men.

21 January 2018

1 reference

Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study

21 January 2018

1 reference

Dyspepsia in HIV-infected patients under highly active antiretroviral therapy.

21 January 2018

1 reference

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

21 January 2018

1 reference

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

21 January 2018

1 reference

Bisphosphonates for osteoporosis--where do we go from here?

21 January 2018

1 reference

Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study

21 January 2018

1 reference

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International

21 January 2018

1 reference

Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

21 January 2018

1 reference

Smoking and fracture risk: a meta-analysis

21 January 2018

1 reference

Alcohol consumption is associated with poor health in HIV clinic patient population: a behavioral surveillance study

21 January 2018

1 reference

Physical activity, body mass index and bone mineral density-associations in a prospective population-based cohort of women and men: the Canadian Multicentre Osteoporosis Study (CaMos).

21 January 2018

1 reference

Aerobic exercise interventions for adults living with HIV/AIDS

21 January 2018

1 reference

Development of evidence-based exercise recommendations for older HIV-infected patients

21 January 2018

1 reference

CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis

21 January 2018

1 reference

Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women

21 January 2018

1 reference

Weight loss and wasting in patients infected with human immunodeficiency virus

21 January 2018

1 reference

RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men

21 January 2018

1 reference

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1257

1 reference

28 August 2017

1 reference